Access the full text.
Sign up today, get DeepDyve free for 14 days.
Ping Wang, Yinhuan Song, Yanjun Zhao, Aiping Fan (2013)Hydroxylamine amplified gold nanoparticle-based aptameric system for the highly selective and sensitive detection of platelet-derived growth factor.
Avi Schroeder, Michael Goldberg, C. Kastrup, Yingxia Wang, Shan Jiang, Brian Joseph, Christopher Levins, S. Kannan, R. Langer, Daniel Anderson (2012)Remotely activated protein-producing nanoparticles.
Nano letters, 12 6
R. Ramanathan, S. Hamburg, M. Borad, M. Seetharam, M. Kundranda, Peter Lee, P. Fredlund, M. Gilbert, Cathy Mast, S. Semple, A. Judge, Brynne Crowell, L. Vocila, I. Maclachlan, D. Northfelt (2013)Abstract LB-289: A phase I dose escalation study of TKM-080301, a RNAi therapeutic directed against PLK1, in patients with advanced solid tumors.
Cancer Research, 73
K Wang, M You, Y Chen, D Han, Z Zhu, J Huang, K Williams, CJ Yang, W Tan (2011)Self-assembly of a bifunctional DNA carrier for drug delivery
Angew Chem Int Ed Engl, 50
C. Ferreira, Melissa Cheung, S. Missailidis, S. Bisland, J. Gariépy (2008)Phototoxic aptamers selectively enter and kill epithelial cancer cells
Nucleic Acids Research, 37
J. Koziara, Tyler Whisman, M. Tseng, R. Mumper (2006)In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors.
Journal of controlled release : official journal of the Controlled Release Society, 112 3
J. Healy, Scott Lewis, M. Kurz, Ryan Boomer, K. Thompson, Charles Wilson, T. Mccauley (2004)Pharmacokinetics and Biodistribution of Novel Aptamer Compositions
Pharmaceutical Research, 21
Yuka Kato, N. Minakawa, Y. Komatsu, H. Kamiya, Naoki Ogawa, H. Harashima, A. Matsuda (2005)New NTP analogs: the synthesis of 4′-thioUTP and 4′-thioCTP and their utility for SELEX
Nucleic Acids Research, 33
K. He, K. Porter, A. Hasan, J. and, B. Shaw (1999)Synthesis of 5-substituted 2'-deoxycytidine 5'-(alpha-P-borano)triphosphates, their incorporationinto DNA and effects on exonuclease.
Nucleic acids research, 27 8
W. Tan, Hui Wang, Yan Chen, Xiaobing Zhang, Haizhen Zhu, C. Yang, Ronghua Yang, Chen Liu (2011)Molecular aptamers for drug delivery.
Trends in biotechnology, 29 12
Liu Yang, Xiaobing Zhang, Mao Ye, Jian-hui Jiang, Ronghua Yang, Ting Fu, Yan Chen, Kemin Wang, Chen Liu, W. Tan (2011)Aptamer-conjugated nanomaterials and their applications.
Advanced drug delivery reviews, 63 14-15
E. Cunningham, A. Adamis, M. Altaweel, L. Aiello, N. Bressler, D. D’Amico, M. Goldbaum, D. Guyer, B. Katz, Manju Patel, S. Schwartz (2005)A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.
Ophthalmology, 112 10
A. Hector, E. Montgomery, Collins Karikari, M. Canto, K. Dunbar, Jean Wang, G. Feldmann, Seung‐Mo Hong, Michael Haffner, A. Meeker, S. Holland, Jiaxin Yu, Thilo Heckrodt, Jing Zhang, Pingyu Ding, D. Goff, Rajinder Singh, J. Roa, Arivusudar Marimuthu, G. Riggins, J. Eshleman, B. Nelkin, A. Pandey, A. Maitra (2010)The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma
Cancer Biology & Therapy, 10
A. Verma, F. Stellacci (2010)Effect of surface properties on nanoparticle-cell interactions.
Small, 6 1
Albert Chen, I. Migliaccio, M. Rimawi, S. López-Tarruella, C. Creighton, S. Massarweh, Catherine Huang, Yen-chao Wang, S. Batra, M. Gutiérrez, C. Osborne, R. Schiff (2012)Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies
Breast Cancer Research and Treatment, 134
M. Petersen, K. Bondensgaard, J. Wengel, J. Jacobsen (2002)Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA:RNA hybrids.
Journal of the American Chemical Society, 124 21
D. Daniels, Hang Chen, B. Hicke, K. Swiderek, L. Gold (2003)A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment
Proceedings of the National Academy of Sciences of the United States of America, 100
Kaylie Young, A. Scott, Liangliang Hao, Sarah Mirkin, Guoliang Liu, C. Mirkin (2012)Hollow spherical nucleic acids for intracellular gene regulation based upon biocompatible silica shells.
Nano letters, 12 7
H. Brem, S. Piantadosi, S. Piantadosi, P. Burger, M. Walker, R. Selker, N. Vick, K. Black, M. Sisti, S. Brem, G. Mohr, P. Muller, R. Morawetz, S. Schold (1995)Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
The Lancet, 345
H. Hatakeyama, H. Akita, H. Harashima (2013)The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors.
Biological & pharmaceutical bulletin, 36 6
A. el-Ghannam, Krista Ricci, Ahmed Malkawi, Kiarash Jahed, Kumar Vedantham, Heather Wyan, Lauren Allen, D. Dréau (2010)A ceramic-based anticancer drug delivery system to treat breast cancer
Journal of Materials Science: Materials in Medicine, 21
Juanjuan Peng, Lingzhi Zhao, Xingjun Zhu, Yun Sun, Wei Feng, Yanhong Gao, Liya Wang, Fuyou Li (2013)Hollow silica nanoparticles loaded with hydrophobic phthalocyanine for near-infrared photodynamic and photothermal combination therapy.
Biomaterials, 34 32
Ka-To Shum, Jiehua Zhou, J. Rossi (2013)Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma
Journal of cancer therapy, 4
J. Sheehan, H. Lan (1998)Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex.
Blood, 92 5
A. Etame, R. Diaz, M. O'Reilly, Christian Smith, T. Mainprize, K. Hynynen, J. Rutka (2012)Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound.
Nanomedicine : nanotechnology, biology, and medicine, 8 7
J. Thigpen (2012)Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Yearbook of Oncology, 2012
Z Li, JC Barnes, A Bosoy, JF Stoddart, JI Zink (2012)Mesoporous silica nanoparticles in biomedical applications
Chem Soc Rev, 41
S. Taghdisi, K. Abnous, F. Mosaffa, J. Behravan (2010)Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer
Journal of Drug Targeting, 18
Jin-quan Zhang, Yong-Sheng Wang, Jinhua Xue, Yan He, Hui-xian Yang, Junfei Liang, Lin-Fei Shi, Xi‐lin Xiao (2012)A gold nanoparticles-modified aptamer beacon for urinary adenosine detection based on structure-switching/fluorescence-"turning on" mechanism.
Journal of pharmaceutical and biomedical analysis, 70
(2011)One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells
Xu Wu, Min Wu, J. Zhao (2014)Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.
Nanomedicine : nanotechnology, biology, and medicine, 10 2
Jason Jaetao, Kimberly Butler, N. Adolphi, Debbie Lovato, H. Bryant, I. Rabinowitz, S. Winter, T. Tessier, H. Hathaway, C. Bergemann, E. Flynn, R. Larson (2009)Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles.
Cancer research, 69 21
Lloyd Aiello, Robert Avery, P. Arrigg, Bruce Keyt, Henry Jampel, Sabera Shah, Louis Pasquale, Hagen Thieme, Mami Iwamoto, John Park (1994)Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
The New England journal of medicine, 331 22
M. Ara, M. Hyodo, N. Ohga, K. Hida, H. Harashima (2012)Development of a Novel DNA Aptamer Ligand Targeting to Primary Cultured Tumor Endothelial Cells by a Cell-Based SELEX Method
PLoS ONE, 7
Seyed Jalalian, S. Taghdisi, Nasim Hamedani, S. Kalat, P. Lavaee, M. Zandkarimi, N. Ghows, M. Jaafari, S. Naghibi, Noor Danesh, M. Ramezani, K. Abnous (2013)Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 50 2
Cui Chen, J. Geng, Fang Pu, Xinjian Yang, Jinsong Ren, Xiaogang Qu (2011)Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery.
Angewandte Chemie, 50 4
Eunjung Kim, Yukyung Jung, Hyangtae Choi, Jaemoon Yang, J. Suh, Yong-Min Huh, Kunhong Kim, S. Haam (2010)Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
Biomaterials, 31 16
É. Dausse, Sonia Gomes, J. Toulmé (2009)Aptamers: a new class of oligonucleotides in the drug discovery pipeline?
Current opinion in pharmacology, 9 5
Huan Meng, Min Xue, T. Xia, Yan-Li Zhao, F. Tamanoi, J. Stoddart, J. Zink, A. Nel (2010)Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves.
Journal of the American Chemical Society, 132 36
L. Du, Siqingaowa Suo, Guangqing Wang, Hongying Jia, Ke-Jian Liu, Baolu Zhao, Yang Liu (2013)Mechanism and cellular kinetic studies of the enhancement of antioxidant activity by using surface-functionalized gold nanoparticles.
Chemistry, 19 4
P. Sundaram, J. Wower, M. Byrne (2012)A nanoscale drug delivery carrier using nucleic acid aptamers for extended release of therapeutic.
Nanomedicine : nanotechnology, biology, and medicine, 8 7
Jonghoon Kang, M. Lee, J. Copland, B. Luxon, D. Gorenstein (2008)Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein.
Bioorganic & medicinal chemistry letters, 18 6
S. Dhar, Nagesh Kolishetti, S. Lippard, O. Farokhzad (2011)Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
Proceedings of the National Academy of Sciences, 108
Yu‐Fen Huang, D. Shangguan, Haipeng Liu, Joseph Phillips, Xiaoling Zhang, Yan Chen, W. Tan (2009)Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor Cells
W. Barchet, Vera Wimmenauer, M. Schlee, G. Hartmann (2008)Accessing the therapeutic potential of immunostimulatory nucleic acids.
Current opinion in immunology, 20 4
R. Bazak, Mohamad Houri, S. Achy, Serag Kamel, T. Refaat (2015)Cancer active targeting by nanoparticles: a comprehensive review of literature
Journal of Cancer Research and Clinical Oncology, 141
M. Mehren, M. Bookman, N. Meropol, L. Weiner, E. Sherman, Jinhui Li, R. Knoblauch, T. Parekh, R. Cohen (2015)Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies
Cancer Chemotherapy and Pharmacology, 75
M. Kuwahara, N. Sugimoto (2010)Molecular Evolution of Functional Nucleic Acids with Chemical Modifications
V. Guarneri, M. Dieci, P. Conte (2012)Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer
Expert Opinion on Pharmacotherapy, 13
Jijumon Chelliserrykattil, A. Ellington (2004)Evolution of a T7 RNA polymerase variant that transcribes 2′-O-methyl RNA
Nature Biotechnology, 22
Y. Hattori, Y. Maitani (2005)Folate-linked lipid-based nanoparticle for targeted gene delivery.
Current drug delivery, 2 3
S. Smitha, K. Gopchandran (2013)Surface enhanced Raman scattering, antibacterial and antifungal active triangular gold nanoparticles.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 102
Daniela Proske, S. Gilch, F. Wopfner, H. Schätzl, E. Winnacker, M. Famulok (2002)Prion‐Protein‐Specific Aptamer Reduces PrPSc Formation
C. Esposito, S. Catuogno, V. Franciscis, L. Cerchia (2011)New insight into clinical development of nucleic acid aptamers.
Discovery medicine, 11 61
A. Etame, Christian Smith, W. Chan, J. Rutka (2011)Design and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculature.
Nanomedicine : nanotechnology, biology, and medicine, 7 6
Y. Lin, D. Nieuwlandt, A. Magallanez, B. Feistner, S. Jayasena (1996)High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro-selected 2'-amino-modified RNA.
Nucleic acids research, 24 17
R. Linger, A. Keating, H. Earp, D. Graham (2008)TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.
Advances in cancer research, 100
Chuanliu Wu, Chen Chen, Jinping Lai, Jianbin Chen, Xue Mu, Jinsheng Zheng, Yibing Zhao (2008)Molecule-scale controlled-release system based on light-responsive silica nanoparticles.
Chemical communications, 23
M. Kuwahara, S. Obika (2013)In vitro selection of BNA (LNA) aptamers
Artificial DNA: PNA & XNA, 4
J. Layzer, A. McCaffrey, Alice Tanner, Zan Huang, M. Kay, B. Sullenger (2004)In vivo activity of nuclease-resistant siRNAs.
RNA, 10 5
H Brem, S Piantadosi, PC Burger, M Walker, R Selker, NA Vick, K Black, M Sisti, S Brem, G Mohr (1995)Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The polymer-brain tumor treatment group
S. Dhar, F. Gu, R. Langer, O. Farokhzad, S. Lippard (2008)Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles
Proceedings of the National Academy of Sciences, 105
Jie Zhu, He Huang, S. Dong, Liang Ge, Yuan Zhang (2014)Progress in Aptamer-Mediated Drug Delivery Vehicles for Cancer Targeting and Its Implications in Addressing Chemotherapeutic Challenges
Preethy Prasad, Ji Cheng, A. Shuhendler, A. Rauth, X. Wu (2012)A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells
Drug Delivery and Translational Research, 2
L. Jia, Jingyi Shen, Zhenyu Li, Dianrui Zhang, Qiang Zhang, Guangpu Liu, Dandan Zheng, Xiaona Tian (2013)In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes.
International journal of pharmaceutics, 445 1-2
M. Fa, A. Radeghieri, Allison Henry, F. Romesberg (2004)Expanding the substrate repertoire of a DNA polymerase by directed evolution.
Journal of the American Chemical Society, 126 6
S. Libutti, G. Paciotti, A. Byrnes, H. Alexander, W. Gannon, M. Walker, G. Seidel, N. Yuldasheva, L. Tamarkin (2010)Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Clinical Cancer Research, 16
N. Jo, C. Mailhos, M. Ju, Eunice Cheung, John Bradley, K. Nishijima, G. Robinson, A. Adamis, D. Shima (2006)Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization.
The American journal of pathology, 168 6
P. Bouchard, R. Hutabarat, K. Thompson (2010)Discovery and development of therapeutic aptamers.
Annual review of pharmacology and toxicology, 50
S. Gurunathan, Kyung-jin Lee, K. Kalishwaralal, Sardarpasha Sheikpranbabu, R. Vaidyanathan, S. Eom (2009)Antiangiogenic properties of silver nanoparticles.
Biomaterials, 30 31
M. Westphal, Z. Ram, V. Riddle, D. Hilt, E. Bortey, O. Group (2006)Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial
Acta Neurochirurgica, 148
J. Kanwar, K. Roy, R. Kanwar (2011)Chimeric aptamers in cancer cell-targeted drug delivery
Critical Reviews in Biochemistry and Molecular Biology, 46
Meghna Talekar, J. Kendall, W. Denny, S. Garg (2011)Targeting of nanoparticles in cancer: drug delivery and diagnostics
Anti-Cancer Drugs, 22
C. Buerger, B. Groner (2003)Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling
Journal of Cancer Research and Clinical Oncology, 129
Y. Lin, Q. Qiu, S. Gill, S. Jayasena (1994)Modified RNA sequence pools for in vitro selection.
Nucleic acids research, 22 24
H. Maeda (2001)The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.
Advances in enzyme regulation, 41
Le-Le Li, Mengying Xie, Jie Wang, Xinyang Li, Cheng Wang, Quan Yuan, D. Pang, Yi Lu, W. Tan (2013)A vitamin-responsive mesoporous nanocarrier with DNA aptamer-mediated cell targeting.
Chemical communications, 49 52
S Dhar, FX Gu, R Langer, OC Farokhzad, SJ Lippard (2008)Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
Proc Natl Acad Sci USA, 105
Zhi-Quan Huang, Hai‐gang Li, Qi Huang, Dan Chen, Jingjing Han, Lili Wang, Chanbin Pan, Weiliang Chen, M. House, K. Nephew, Zhongmin Guo (2014)SERPINB2 down‐regulation contributes to chemoresistance in head and neck cancer
Molecular Carcinogenesis, 53
Zhe Liu, J. Duan, Yong-mei Song, Jie Ma, Fengdan Wang, Xin Lu, Xian-da Yang (2012)Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
Journal of Translational Medicine, 10
R. Lambert (1990)Photodynamic Therapy for Esophageal cancer
Canadian Journal of Gastroenterology & Hepatology, 4
R. Siegel, K. Miller, A. Jemal (2015)Cancer statistics, 2015
CA: A Cancer Journal for Clinicians, 65
Arun Sharma, N. Jain, Rashmi Sareen (2013)Nanocarriers for Diagnosis and Targeting of Breast Cancer
BioMed Research International, 2013
L. Maggiorella, G. Barouch, Corinne Devaux, A. Pottier, E. Deutsch, J. Bourhis, E. Borghi, L. Lévy (2012)Nanoscale radiotherapy with hafnium oxide nanoparticles.
Future oncology, 8 9
Clare Nicol, D. Bunka, G. Blair, N. Stonehouse (2011)Effects of single nucleotide changes on the binding and activity of RNA aptamers to human papillomavirus 16 E7 oncoprotein.
Biochemical and biophysical research communications, 405 3
Neetu Singh, A. Karambelkar, Luo Gu, K. Lin, Jordan Miller, Christopher Chen, M. Sailor, S. Bhatia (2011)Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release
Journal of the American Chemical Society, 133
P. Hagedorn, V. Yakimov, S. Ottosen, S. Kammler, N. Nielsen, A. Høg, M. Hedtjärn, M. Meldgaard, M. Møller, H. Orum, T. Koch, M. Lindow (2013)Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification pattern.
Nucleic acid therapeutics, 23 5
S. Taghdisi, Noor Danesh, Ahmad Emrani, K. Tabrizian, M. Zandkarimi, M. Ramezani, K. Abnous (2013)Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer
Journal of Drug Targeting, 21
In‐Hyun Lee, Sukyung An, M. Yu, Ho-Keun Kwon, S. Im, S. Jon (2011)Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates.
Journal of controlled release : official journal of the Controlled Release Society, 155 3
G. Biesecker, L. Dihel, K. Enney, R. Bendele (1999)Derivation of RNA aptamer inhibitors of human complement C5.
Immunopharmacology, 42 1-3
Carrie Chong, Min Cao, W. Wong, K. Fischer, W. Addison, G. Kwon, D. Tyrrell, J. Samuel (2005)Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
Journal of controlled release : official journal of the Controlled Release Society, 102 1
Zhongdong Chen, Xiang Li, Haiyan He, Z. Ren, Y. Liu, Juan Wang, Zhe Li, G. Shen, G. Han (2012)Mesoporous silica nanoparticles with manipulated microstructures for drug delivery.
Colloids and surfaces. B, Biointerfaces, 95
M. Kieran, R. Kalluri, Yoon-Jae Cho (2012)The VEGF pathway in cancer and disease: responses, resistance, and the path forward.
Cold Spring Harbor perspectives in medicine, 2 12
Jung Lee, M. Yigit, Debapriya Mazumdar, Yi Lu (2010)Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates.
Advanced drug delivery reviews, 62 6
T. Feczkó, J. Tóth, Gy. Dósa, J. Gyenis (2011)Influence of process conditions on the mean size of PLGA nanoparticles
Chemical Engineering and Processing, 50
M. Masud, M. Kuwahara, H. Ozaki, H. Sawai (2004)Sialyllactose-binding modified DNA aptamer bearing additional functionality by SELEX.
Bioorganic & medicinal chemistry, 12 5
Mohamed Qaddoumi, H. Ueda, Johnny Yang, J. Davda, V. Labhasetwar, V. Lee (2004)The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjunctival Epithelial Cell Layers
Pharmaceutical Research, 21
Troels Jensen, A. Pasternak, Andreas Madsen, M. Petersen, J. Wengel (2011)Synthesis and Structural Characterization of 2′‐Fluoro‐α‐L‐RNA‐Modified Oligonucleotides
E. Bergmann-Leitner (2005)Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner]
Current Pharmaceutical Design, 15
R. Stoltenburg, C. Reinemann, B. Strehlitz (2007)SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
Biomolecular engineering, 24 4
C Chen, J Geng, F Pu, X Yang, J Ren, X Qu (2011)Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery
Angew Chem Int Ed Engl, 50
M. Kemp, Ashavani Kumar, Shaymaa Mousa, E. Dyskin, Murat Yalcin, P. Ajayan, R. Linhardt, S. Mousa (2009)Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties
R. Lehn, M. Ricci, P. Silva, P. Andreozzi, J. Reguera, K. Voïtchovsky, F. Stellacci, A. Alexander-Katz (2014)Lipid tail protrusions mediate the insertion of nanoparticles into model cell membranes
Nature Communications, 5
Jianwei Guo, Xiaoling Gao, Lina Su, Huimin Xia, Guangzhi Gu, Z. Pang, Xin-guo Jiang, L. Yao, Jun Chen, Hongzhuan Chen (2011)Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Biomaterials, 32 31
Hongru Liang, Gui-qiu Hu, Zhang Tao, Yu-jiao Yang, Lili Zhao, Yinglin Qi, Hualei Wang, Yuwei Gao, Songtao Yang, X. Xia (2012)Isolation of ssDNA aptamers that inhibit rabies virus.
International immunopharmacology, 14 3
C. Tuerk, L. Gold (1990)Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.
Science, 249 4968
R. Arvizo, S. Rana, Oscar Miranda, Resham Bhattacharya, V. Rotello, P. Mukherjee (2011)Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge.
Nanomedicine : nanotechnology, biology, and medicine, 7 5
D. Giljohann, D. Seferos, Andrew Prigodich, Pinal Patel, C. Mirkin (2009)Gene regulation with polyvalent siRNA-nanoparticle conjugates.
Journal of the American Chemical Society, 131 6
F. Hernandez, Luiza Hernandez, A. Pinto, T. Schäfer, V. Özalp (2013)Targeting cancer cells with controlled release nanocapsules based on a single aptamer.
Chemical communications, 49 13
Y. Chushak, M. Stone (2009)In silico selection of RNA aptamers
Nucleic Acids Research, 37
K. Porter, J. Briley, Barbara Shaw (1997)Direct PCR sequencing with boronated nucleotides.
Nucleic acids research, 25 8
G. Zhu, Mao Ye, M. Donovan, Erqun Song, Zilong Zhao, W. Tan (2012)Nucleic acid aptamers: an emerging frontier in cancer therapy.
Chemical communications, 48 85
Kejing Zhang, K. Sefah, L. Tang, Zilong Zhao, G. Zhu, Mao Ye, Weijia Sun, S. Goodison, W. Tan (2012)A Novel Aptamer Developed for Breast Cancer Cell Internalization
Y. Shieh, Shu-Jyuan Yang, M. Wei, M. Shieh (2010)Aptamer-based tumor-targeted drug delivery for photodynamic therapy.
ACS nano, 4 3
JE Zuckerman, I Gritli, A Tolcher, JD Heidel, D Lim, R Morgan, B Chmielowski, A Ribas, ME Davis, Y Yen (2014)Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
Proc Natl Acad Sci USA, 111
N. Subramanian, Vaishnavi Raghunathan, J. Kanwar, R. Kanwar, Sailaja Elchuri, V. Khetan, S. Krishnakumar (2012)Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer
Molecular Vision, 18
S. Henry, H. Bolte, C. Auletta, D. Kornbrust (1997)Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys.
Toxicology, 120 2
F. Perche, V. Torchilin (2013)Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting
Journal of Drug Delivery, 2013
J. Toscano-Garibay, M. Benítez-Hess, L. Alvarez-Salas (2011)Isolation and characterization of an RNA aptamer for the HPV-16 E7 oncoprotein.
Archives of medical research, 42 2
S. Blaser, M. Scheringer, M. MacLeod, K. Hungerbühler (2008)Estimation of cumulative aquatic exposure and risk due to silver: contribution of nano-functionalized plastics and textiles.
The Science of the total environment, 390 2-3
J. Vasir, V. Labhasetwar (2007)Biodegradable nanoparticles for cytosolic delivery of therapeutics.
Advanced drug delivery reviews, 59 8
K. Dreher (2003)Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles.
Toxicological sciences : an official journal of the Society of Toxicology, 77 1
DA Daniels, H Chen, BJ Hicke, KM Swiderek, L Gold (2003)A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment
Proc Natl Acad Sci USA, 100
Y Zhang, H. Hong, W. Cai (2011)Tumor-targeted drug delivery with aptamers.
Current medicinal chemistry, 18 27
Liping Qiu, Tao Chen, İsmail Öçsoy, Emir Yasun, Cuichen Wu, G. Zhu, M. You, Da Han, Jian-hui Jiang, R. Yu, W. Tan (2014)A Cell-Targeted, Size-Photocontrollable, Nuclear-Uptake Nanodrug Delivery System for Drug-Resistant Cancer Therapy
Nano Letters, 15
E. Gordon, F. Hall (2010)Rexin-G, a targeted genetic medicine for cancer
Expert Opinion on Biological Therapy, 10
Wenhu Zhou, Yanbin Zhou, Jianping Wu, Zhenbao Liu, Huanzhe Zhao, Juewen Liu, Jinsong Ding (2014)Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells
Journal of Drug Targeting, 22
J. Lee, N. Lee, Hyoungsu Kim, Jaeyun Kim, S. Choi, J. Kim, Taeho Kim, I. Song, Seung Park, W. Moon, T. Hyeon (2010)Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery.
Journal of the American Chemical Society, 132 2
M. Fassnacht, M. Terzolo, B. Allolio, E. Baudin, H. Haak, A. Berruti, S. Welin, C. Schade-Brittinger, A. Lacroix, B. Jarzab, H. Sorbye, D. Torpy, V. Stepan, D. Schteingart, W. Arlt, M. Kroiss, S. Leboulleux, P. Sperone, A. Sundin, I. Hermsen, S. Hahner, H. Willenberg, A. Tabarin, M. Quinkler, C. Fouchardière, M. Schlumberger, F. Mantero, D. Weismann, F. Beuschlein, H. Gelderblom, H. Wilmink, M. Sender, M. Edgerly, W. Kenn, T. Fojo, H. Müller, B. Skogseid (2012)Combination chemotherapy in advanced adrenocortical carcinoma.
The New England journal of medicine, 366 23
Kendall Frazier (2015)Antisense Oligonucleotide Therapies
Toxicologic Pathology, 43
S. Gopinath, Penmetcha Kumar (2013)Aptamers that bind to the hemagglutinin of the recent pandemic influenza virus H1N1 and efficiently inhibit agglutination.
Acta biomaterialia, 9 11
Guilin Wang, H. Uludaǧ (2008)Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles
Expert Opinion on Drug Delivery, 5
R. Shukla, V. Bansal, Minakshi Chaudhary, A. Basu, R. Bhonde, M. Sastry (2005)Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview.
Langmuir : the ACS journal of surfaces and colloids, 21 23
A. Gabizon, R. Isacson, E. Libson, Bella Kaufman, B. Uziely, R. Catane, C. Ben–Dor, Elio Rabello, Yaacov Cass, Tamar Peretz, A. Sulkes, R. Chisin, Y. Barenholz (1994)Clinical studies of liposome-encapsulated doxorubicin.
Acta oncologica, 33 7
苗红霞, 贾彩红, 张建斌, 王卓, 徐碧玉, 刘菊华, 金志强, 胡伟, 张静 (2015)Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening
Cui Chen, Li Zhou, J. Geng, Jinsong Ren, Xiaogang Qu (2013)Photosensitizer-incorporated quadruplex DNA-gated nanovechicles for light-triggered, targeted dual drug delivery to cancer cells.
Small, 9 16
Juan Li, Cheng Zheng, Sena Cansiz, Cuichen Wu, Jiehua Xu, Cheng Cui, Yuan Liu, Weijia Hou, Yanyue Wang, Liqin Zhang, I-ting Teng, Huang-Hao Yang, W. Tan (2015)Self-assembly of DNA Nanohydrogels with Controllable Size and Stimuli-Responsive Property for Targeted Gene Regulation Therapy
Journal of the American Chemical Society, 137
F. Gourronc, W. Rockey, William Thiel, P. Giangrande, A. Klingelhutz (2013)Identification of RNA aptamers that internalize into HPV-16 E6/E7 transformed tonsillar epithelial cells.
Virology, 446 1-2
Paula Burmeister, Scott Lewis, Robert Silva, J. Preiss, Lillian Horwitz, P. Pendergrast, T. Mccauley, J. Kurz, D. Epstein, Charles Wilson, A. Keefe (2005)Direct in vitro selection of a 2'-O-methyl aptamer to VEGF.
Chemistry & biology, 12 1
J. Sung, J. Ji, J. Park, M. Song, K. Song, Hyeon Ryu, J. Yoon, K. Jeon, Jayoung Jeong, B. Han, Y. Chung, H. Chang, J. Lee, Dong Kim, B. Kelman, I. Yu (2011)Subchronic inhalation toxicity of gold nanoparticles
Particle and Fibre Toxicology, 8
Zihan Lin, Q. Ma, Xiaofang Fei, Hao Zhang, X. Su (2014)A novel aptamer functionalized CuInS2 quantum dots probe for daunorubicin sensing and near infrared imaging of prostate cancer cells.
Analytica chimica acta, 818
J. Strand, Zohreh Varasteh, O. Eriksson, L. Abrahmsén, A. Orlova, V. Tolmachev (2014)Gallium-68-labeled affibody molecule for PET imaging of PDGFRβ expression in vivo.
Molecular pharmaceutics, 11 11
Min Liu, Didi Chen, Chenxu Wang, Xunhu Chen, Zhili Wen, Yu Cao, Hongxuan He (2015)Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance
Journal of Drug Targeting, 23
J. Binning, Tianjiao Wang, P. Luthra, Reed Shabman, D. Borek, Gai Liu, W. Xu, D. Leung, C. Basler, G. Amarasinghe (2013)Development of RNA aptamers targeting Ebola virus VP35.
Biochemistry, 52 47
V. Gonzalez, G. Giuliari, R. Banda, D. Guel (2009)Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy
British Journal of Ophthalmology, 93
D. Jellinek, L. Green, C. Bell, C. Lynott, N. Gill, C. Vargeese, G. Kirschenheuter, D. McGee, P. Abesinghe, W. Pieken (1995)Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor.
Biochemistry, 34 36
Sehoon Kim, Tymish Ohulchanskyy, D. Bharali, Yihui Chen, R. Pandey, P. Prasad (2009)Organically Modified Silica Nanoparticles with Intraparticle Heavy-Atom Effect on the Encapsulated Photosensitizer for Enhanced Efficacy of Photodynamic Therapy.
The journal of physical chemistry. C, Nanomaterials and interfaces, 113
U. Chakravarthy, A. Adamis, E. Cunningham, M. Goldbaum, D. Guyer, B. Katz, Manju Patel (2006)Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
Ophthalmology, 113 9
A. Jones, Nicholas Cross (2004)Oncogenic derivatives of platelet-derived growth factor receptors.
Cellular and molecular life sciences : CMLS, 61 23
Dimitri Simaeys, D. Lopez-Colon, K. Sefah, R. Sutphen, E. Jiménez, W. Tan (2010)Study of the Molecular Recognition of Aptamers Selected through Ovarian Cancer Cell-SELEX
PLoS ONE, 5
Michael Werner, S. Karve, R. Sukumar, Natalie Cummings, Jonathan Copp, Ronald Chen, Tian Zhang, Andrew Wang (2011)Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis.
Biomaterials, 32 33
Ye Zhu, Pranjal Chandra, Y. Shim (2013)Ultrasensitive and selective electrochemical diagnosis of breast cancer based on a hydrazine-Au nanoparticle-aptamer bioconjugate.
Analytical chemistry, 85 2
M. Lamberti, N. Vittar, V. Rivarola (2014)Breast cancer as photodynamic therapy target: Enhanced therapeutic efficiency by overview of tumor complexity.
World journal of clinical oncology, 5 5
SM Rafiyath, M Rasul, B Lee, G Wei, G Lamba, D Liu (2012)Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis. Exp
Hematol Oncol, 1
Prabodhika Mallikaratchy, Zhiwen Tang, W. Tan (2008)Cell Specific Aptamer–Photosensitizer Conjugates as a Molecular Tool in Photodynamic Therapy
Suzanne D'Addio, R. Prud’homme (2011)Controlling drug nanoparticle formation by rapid precipitation.
Advanced drug delivery reviews, 63 6
Sanjay Singh, Ravindra Kumar, J. Wengel (1998)Synthesis of Novel Bicyclo[2.2.1] Ribonucleosides: 2'-Amino- and 2'-Thio-LNA Monomeric Nucleosides.
The Journal of organic chemistry, 63 18
K. Du, R. Mick, T. Busch, T. Zhu, J. Finlay, G. Yu, A. Yodh, S. Malkowicz, D. Smith, R. Whittington, D. Stripp, S. Hahn (2006)Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer
Lasers in Surgery and Medicine, 38
A. Seaton, L. Tran, R. Aitken, K. Donaldson (2010)Nanoparticles, human health hazard and regulation
Journal of The Royal Society Interface, 7
S. Brown, P. Nativo, Jo-Ann Smith, David Stirling, P. Edwards, B. Venugopal, D. Flint, J. Plumb, D. Graham, N. Wheate (2010)Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin
Journal of the American Chemical Society, 132
Da Han, G. Zhu, Cuichen Wu, Zhi Zhu, Tao Chen, Xiaobing Zhang, W. Tan (2013)Engineering a cell-surface aptamer circuit for targeted and amplified photodynamic cancer therapy.
ACS nano, 7 3
Jie Chen, Hao Wang, Wei Long, Xiu Shen, Di Wu, Sha-sha Song, Yuan-ming Sun, Peixun Liu, Saijun Fan, Fei-yue Fan, Xiao-dong Zhang (2013)Sex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in mice
International Journal of Nanomedicine, 8
Ji-Ho Park, Luo Gu, G. Maltzahn, E. Ruoslahti, S. Bhatia, M. Sailor (2009)Biodegradable luminescent porous silicon nanoparticles for in vivo applications.
Nature materials, 8 4
Zhiwen Tang, D. Shangguan, Kemin Wang, Hui Shi, K. Sefah, Prabodhika Mallikratchy, H. Chen, Y. Li, W. Tan (2007)Selection of aptamers for molecular recognition and characterization of cancer cells.
Analytical chemistry, 79 13
NL Rosi, DA Giljohann, CS Thaxton, AK Lytton-Jean, MS Han, CA Mirkin (2006)Oligonucleotide-modified gold nanoparticles for intracellular gene regulation
D. Willner, P. Trail, S. Hofstead, H. King, S. Lasch, G. Braslawsky, R. Greenfield, T. Kaneko, R. Firestone (1993)(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.
Bioconjugate chemistry, 4 6
A. Kumari, S. Yadav, S. Yadav (2010)Biodegradable polymeric nanoparticles based drug delivery systems.
Colloids and surfaces. B, Biointerfaces, 75 1
Kelong Wang, M. You, Yan Chen, Dae-Suk Han, Zhi Zhu, Jin Huang, Kathryn Williams, C. Yang, W. Tan (2011)Self-assembly of a bifunctional DNA carrier for drug delivery.
Angewandte Chemie, 50 27
Cindy Farman, D. Kornbrust (2003)Oligodeoxynucleotide Studies in Primates: Antisense and Immune Stimulatory Indications
Toxicologic Pathology, 31
Cindy Meyer, U. Hahn, A. Rentmeister (2011)Cell-Specific Aptamers as Emerging Therapeutics
Journal of Nucleic Acids, 2011
M. Muthu, D. Leong, Lin Mei, S. Feng (2014)Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics
Yan Hu, J. Duan, Q. Zhan, Fengdan Wang, Xin Lu, Xian-da Yang (2012)Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro
PLoS ONE, 7
R. Ackroyd, C. Kelty, N. Brown, T. Stephenson, C. Stoddard, M. Reed (2003)Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up.
Endoscopy, 35 6
O. Tatarinova, V. Tsvetkov, D. Basmanov, N. Barinov, I. Smirnov, E. Timofeev, D. Kaluzhny, A. Chuvilin, D. Klinov, A. Varizhuk, G. Pozmogova (2014)Comparison of the ‘Chemical’ and ‘Structural’ Approaches to the Optimization of the Thrombin-Binding Aptamer
PLoS ONE, 9
J. Datta, Shuwen Xu, C. Rosemblit, J. Smith, Jessica Cintolo, D. Powell, B. Czerniecki (2015)CD4+ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8+ T-cell Targeting of HER2/neu–Expressing Cancers
Cancer Immunology Research, 3
M. McKeague, M. DeRosa (2012)Challenges and Opportunities for Small Molecule Aptamer Development
Journal of Nucleic Acids, 2012
Xiao-yong Ye, Yun Li, S. Stawicki, S. Couto, J. Eastham‐Anderson, Dara Kallop, R. Weimer, Yan Wu, Lin Pei (2010)An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
G. Zuber, C. Muller, J. Behr (2005)Targeted Gene Delivery to Cancer Cells with Nanometric DNA Particles Enveloped with Folic Acid Using a Polymerisable Anchor
Technology in Cancer Research & Treatment, 4
G. Zhu, Ling Meng, Mao Ye, Liu Yang, K. Sefah, M. O’Donoghue, Yan Chen, Xiangling Xiong, Jin Huang, Erqun Song, W. Tan (2012)Self-assembled aptamer-based drug carriers for bispecific cytotoxicity to cancer cells.
Chemistry, an Asian journal, 7 7
A. Gabizon, R. Catane, B. Uziely, B. Kaufman, T. Safra, R. Cohen, F. Martín, A. Huang, Y. Barenholz (1994)Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
Cancer research, 54 4
Qiaoling Liu, Li Xu, Xuejie Zhang, Nan Li, Jun-peng Zheng, Mirong Guan, X. Fang, Chunru Wang, Chun-ying Shu (2013)Enhanced photodynamic efficiency of an aptamer-guided fullerene photosensitizer toward tumor cells.
Chemistry, an Asian journal, 8 10
S. Soundararajan, Weiwei Chen, E. Spicer, N. Courtenay-Luck, D. Fernandes (2008)The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
Cancer research, 68 7
Zeyu Xiao, D. Shangguan, Z. Cao, X. Fang, W. Tan (2008)Cell-specific internalization study of an aptamer from whole cell selection.
Chemistry, 14 6
E. Swayze, A. Siwkowski, E. Wancewicz, M. Migawa, T. Wyrzykiewicz, G. Hung, B. Monia, andJohnM. Bennett (2006)Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals
Nucleic Acids Research, 35
T Yano, K Hatogai, H Morimoto, Y Yoda, K Kaneko (2014)Photodynamic therapy for esophageal cancer
Ann Transl Med, 2
S. Camorani, C. Esposito, A. Rienzo, S. Catuogno, M. Iaboni, G. Condorelli, V. Franciscis, L. Cerchia (2014)Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.
Molecular therapy : the journal of the American Society of Gene Therapy, 22 4
Xianbin Yang, S. Fennewald, B. Luxon, J. Aronson, N. Herzog, D. Gorenstein (1999)Aptamers containing thymidine 3'-O-phosphorodithioates: synthesis and binding to nuclear factor-kappaB.
Bioorganic & medicinal chemistry letters, 9 23
Nagesh Kolishetti, S. Dhar, P. Valencia, Lucy Lin, R. Karnik, S. Lippard, R. Langer, O. Farokhzad (2010)Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
Proceedings of the National Academy of Sciences, 107
S. Henry, P. Giclas, J. Leeds, M. Pangburn, C. Auletta, A. Levin, D. Kornbrust (1997)Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action.
The Journal of pharmacology and experimental therapeutics, 281 2
S. Rafiyath, Mohammad Rasul, Byung Lee, G. Wei, Gurpreet Lamba, Delong Liu (2012)Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
Experimental Hematology & Oncology, 1
L. Cerchia, C. Esposito, S. Camorani, A. Rienzo, L. Stasio, L. Insabato, A. Affuso, V. Franciscis (2012)Targeting Axl with an high-affinity inhibitory aptamer.
Molecular therapy : the journal of the American Society of Gene Therapy, 20 12
R. Gref, Y. Minamitake, M. Peracchia, V. Trubetskoy, V. Torchilin, R. Langer (1994)Biodegradable long-circulating polymeric nanospheres.
Science, 263 5153
Cuichen Wu, Da Han, Tao Chen, Lu Peng, G. Zhu, M. You, Liping Qiu, K. Sefah, Xiaobing Zhang, W. Tan (2013)Building a multifunctional aptamer-based DNA nanoassembly for targeted cancer therapy.
Journal of the American Chemical Society, 135 49
Clare Nicol, Özlem Cesur, S. Forrest, T. Belyaeva, D. Bunka, G. Blair, N. Stonehouse (2013)An RNA Aptamer Provides a Novel Approach for the Induction of Apoptosis by Targeting the HPV16 E7 Oncoprotein
PLoS ONE, 8
Yi-Syun Shiao, Huai-hsuan Chiu, P. Wu, Yu‐Fen Huang (2014)Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
ACS applied materials & interfaces, 6 24
Sooyeon Kwon, R. Singh, R. Pérez, E. Neel, H. Kim, W. Chrzanowski (2013)Silica-based mesoporous nanoparticles for controlled drug delivery
Journal of Tissue Engineering, 4
E. Babu, P. Mareeswaran, S. Rajagopal (2012)Highly Sensitive Optical Biosensor for Thrombin Based on Structure Switching Aptamer-Luminescent Silica Nanoparticles
Journal of Fluorescence, 23
A. Verma, S. Warner, H. Vankayalapati, D. Bearss, Sunil Sharma (2011)Targeting Axl and Mer Kinases in Cancer
Molecular Cancer Therapeutics, 10
Cuisong Zhou, Tao Chen, Cuichen Wu, G. Zhu, Liping Qiu, Cheng Cui, Weijia Hou, W. Tan (2015)Aptamer CaCO3 nanostructures: a facile, pH-responsive, specific platform for targeted anticancer theranostics.
Chemistry, an Asian journal, 10 1
N. Bege, Thomas Renette, M. Jansch, R. Reul, Olivia Merkel, H. Petersen, C. Curdy, R. Müller, T. Kissel (2011)Biodegradable poly(ethylene carbonate) nanoparticles as a promising drug delivery system with "stealth" potential.
Macromolecular bioscience, 11 7
S. Holland, Alison Pan, C. Franci, Yuanming Hu, B. Chang, Weiqun Li, M. Duan, Allan Torneros, Jiaxin Yu, Thilo Heckrodt, Jing Zhang, Pingyu Ding, A. Apatira, J. Chua, R. Brandt, P. Pine, D. Goff, Rajinder Singh, D. Payan, Y. Hitoshi (2010)R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.
Cancer research, 70 4
Yun-Ling Luo, Yi-Syun Shiao, Yu‐Fen Huang (2011)Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
ACS nano, 5 10
E. Sayari, M. Dinarvand, M. Amini, M. Azhdarzadeh, E. Mollarazi, Z. Ghasemi, F. Atyabi (2014)MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
International journal of pharmaceutics, 473 1-2
A. Gabizon (1994)Liposomal anthracyclines.
Hematology/oncology clinics of North America, 8 2
J. Zuckerman, Ismael Gritli, A. Tolcher, J. Heidel, D. Lim, R. Morgan, B. Chmielowski, A. Ribas, Mark Davis, Y. Yen (2014)Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
Proceedings of the National Academy of Sciences, 111
S. Weiss, Daniela Proske, Manuela Neumann, M. Groschup, H. Kretzschmar, M. Famulok, E. Winnacker (1997)RNA aptamers specifically interact with the prion protein PrP
Journal of Virology, 71
Shawn Lupold, B. Hicke, Yun Lin, D. Coffey (2002)Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
Cancer research, 62 14
E. Brody, L. Gold (2000)Aptamers as therapeutic and diagnostic agents.
Journal of biotechnology, 74 1
A. Obubuafo, S. Balamurugan, H. Shadpour, D. Spivak, R. McCarley, S. Soper (2008)Poly(methyl methacrylate) microchip affinity capillary gel electrophoresis of aptamer–protein complexes for the analysis of thrombin in plasma
A. Keefe, Sharon Cload (2008)SELEX with modified nucleotides.
Current opinion in chemical biology, 12 4
Mei-Di Hu, Kunhe Zhang (2013)The application of aptamers in cancer research: an up-to-date review.
Future oncology, 9 3
J. Sung, J. Ji, K. Song, J. Lee, Kyung-hee Choi, Sang Lee, I. Yu (2011)Acute inhalation toxicity of silver nanoparticles.
Toxicology and industrial health, 27 2
Chunmei Li, Tao Chen, I. Ocsoy, G. Zhu, Emir Yasun, M. You, Cuichen Wu, Jing Zheng, Erqun Song, Chenghong Huang, W. Tan (2014)Gold‐Coated Fe3O4 Nanoroses with Five Unique Functions for Cancer Cell Targeting, Imaging, and Therapy
Advanced Functional Materials, 24
R. Cuenca, R. Allison, C. Sibata, G. Downie (2004)Breast Cancer With Chest Wall Progression: Treatment With Photodynamic Therapy
Annals of Surgical Oncology, 11
Jin Kim, J. Sung, J. Ji, K. Song, J. Lee, C. Kang, I. Yu (2011)In vivo Genotoxicity of Silver Nanoparticles after 90-day Silver Nanoparticle Inhalation Exposure
Safety and Health at Work, 2
P. Mukherjee, Resham Bhattacharya, Ping Wang, Ling Wang, S. Basu, J. Nagy, A. Atala, D. Mukhopadhyay, S. Soker (2005)Antiangiogenic Properties of Gold Nanoparticles
Clinical Cancer Research, 11
S. Henry, D. Monteith, A. Levin (1997)Antisense oligonucleotide inhibitors for the treatment of cancer: 2. Toxicological properties of phosphorothioate oligodeoxynucleotides.
Anti-cancer drug design, 12 5
X. Fang, W. Tan (2010)Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.
Accounts of chemical research, 43 1
Nathaniel Rosi, D. Giljohann, C. Thaxton, Abigail Lytton-Jean, M. Han, C. Mirkin (2020)Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation*
Spherical Nucleic Acids
Ling Meng, Liu Yang, Xiangxuan Zhao, Lucy Zhang, Haizhen Zhu, Chen Liu, W. Tan (2012)Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer
PLoS ONE, 7
Kathrin Schmidt, S. Borkowski, J. Kurreck, A. Stephens, R. Bald, M. Hecht, M. Friebe, L. Dinkelborg, V. Erdmann (2004)Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.
Nucleic acids research, 32 19
Jinjin Yin, Xiaoxiao He, Kemin Wang, Zhihe Qing, Xu Wu, Hui Shi, Xiaohai Yang (2012)One-step engineering of silver nanoclusters-aptamer assemblies as luminescent labels to target tumor cells.
Nanoscale, 4 1
Zongxi Li, J. Barnes, Aleksandr Bosoy, J. Stoddart, J. Zink (2012)Mesoporous Silica Nanoparticles in Biomedical Applications
Xiaobin Zhao, Hong Li, Robert Lee (2008)Targeted drug delivery via folate receptors.
Expert opinion on drug delivery, 5 3
A. Pottier, E. Borghi, L. Lévy (2014)New use of metals as nanosized radioenhancers.
Anticancer research, 34 1
Z. Ran, Yangfei Sun, Baisong Chang, Q. Ren, Wuli Yang (2013)Silica composite nanoparticles containing fluorescent solid core and mesoporous shell with different thickness as drug carrier.
Journal of colloid and interface science, 410
KS Frazier (2015)Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist?s perspective
Toxicol Pathol, 43
A. Ellington, J. Szostak (1990)In vitro selection of RNA molecules that bind specific ligands
G. Zhu, Rong Hu, Zilong Zhao, Zhuo Chen, Xiaobing Zhang, W. Tan (2013)Noncanonical self-assembly of multifunctional DNA nanoflowers for biomedical applications.
Journal of the American Chemical Society, 135 44
C. Moore, M. Emberton, S. Bown (2011)Photodynamic therapy for prostate cancer—an emerging approach for organ‐confined disease
Lasers in Surgery and Medicine, 43
L. Liao, Jenny Liu, E. Dreaden, Stephen Morton, Kevin Shopsowitz, P. Hammond, Jeremiah Johnson (2014)A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
Journal of the American Chemical Society, 136
Zeyu Xiao, O. Farokhzad (2012)Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities.
ACS nano, 6 5
C. Ireson, L. Kelland (2006)Discovery and development of anticancer aptamers
Molecular Cancer Therapeutics, 5
Mohammed Khan, Gowda Vishakante, Siddaramaiah H (2013)Gold nanoparticles: a paradigm shift in biomedical applications.
Advances in colloid and interface science, 199-200
Zhengxia Liu, Yucheng Wu, Zhirui Guo, Y. Liu, Yujie Shen, P. Zhou, Xiang Lu (2014)Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells
PLoS ONE, 9
(2005)NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
K. Letchford, H. Burt (2007)A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 65 3
B. Musafia, Rony Oren-Banaroya, S. Noiman (2014)Designing Anti-Influenza Aptamers: Novel Quantitative Structure Activity Relationship Approach Gives Insights into Aptamer – Virus Interaction
PLoS ONE, 9
Xiaogang Pan, Robert Lee (2004)Tumour-selective drug delivery via folate receptor-targeted liposomes
Expert Opinion on Drug Delivery, 1
S. Jayasena (1999)Aptamers: an emerging class of molecules that rival antibodies in diagnostics.
Clinical chemistry, 45 9
A. Aravind, Prashanti Jeyamohan, R. Nair, S. Veeranarayanan, Yutaka Nagaoka, Y. Yoshida, T. Maekawa, D. Kumar (2012)AS1411 aptamer tagged PLGA‐lecithin‐PEG nanoparticles for tumor cell targeting and drug delivery
Biotechnology and Bioengineering, 109
L. Harris, G. Batist, R. Belt, Douglas Rovira, R. Navari, N. Azarnia, L. Welles, E. Winer (2002)Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma
Robby Petros, J. Desimone (2010)Strategies in the design of nanoparticles for therapeutic applications
Nature Reviews Drug Discovery, 9
M. Rouf, I. Vural, J. Renoir, A. Hincal (2009)Development and characterization of liposomal formulations for rapamycin delivery and investigation of their antiproliferative effect on MCF7 cells
Journal of Liposome Research, 19
Li Cai, Ze-Zhong Chen, Min-yan Chen, Hongwu Tang, D. Pang (2013)MUC-1 aptamer-conjugated dye-doped silica nanoparticles for MCF-7 cells detection.
Biomaterials, 34 2
P. Sundaram, Helena Kurniawan, M. Byrne, J. Wower (2013)Therapeutic RNA aptamers in clinical trials.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 48 1-2
Zhanxia Zhang, Dóra Balogh, Fuan Wang, Sohn Sung, R. Nechushtai, I. Willner (2013)Biocatalytic release of an anticancer drug from nucleic-acids-capped mesoporous SiO2 Using DNA or molecular biomarkers as triggering stimuli.
ACS nano, 7 10
Chenchen Yu, Yan Hu, J. Duan, W. Yuan, Chen Wang, Haiyan Xu, Xian-da Yang (2011)Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro
PLoS ONE, 6
F. Danhier, E. Ansorena, Joana Silva, R. Coco, Aude Breton, V. Préat (2012)PLGA-based nanoparticles: an overview of biomedical applications.
Journal of controlled release : official journal of the Controlled Release Society, 161 2
R. Sousa, R. Padilla (1995)A mutant T7 RNA polymerase as a DNA polymerase.
The EMBO Journal, 14
Zeyu Xiao, E. Levy-Nissenbaum, F. Alexis, A. Lupták, Benjamin Teply, J. Chan, Jinjun Shi, Elise Digga, Ju-Chen Cheng, R. Langer, O. Farokhzad (2012)Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection.
ACS nano, 6 1
Liyu Li, Jianjun Hou, Xinjie Liu, Yujia Guo, Yun Wu, Lihe Zhang, Zhenjun Yang (2014)Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas.
Biomaterials, 35 12
A. Peterson, J. Heemstra (2015)Controlling self-assembly of DNA-polymer conjugates for applications in imaging and drug delivery.
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 7 3
Conventional delivery of chemotherapeutic agents leads to multiple systemic side effects and toxicity, limiting the doses that can be used. The development of targeted therapies to selectively deliver anti-cancer agents to tumor cells without damaging neighboring unaffected cells would lead to higher effective local doses and improved response rates. Aptamers are single-stranded oligonucleotides that bind to target molecules with both high affinity and high specificity. The high specificity exhibited by aptamers promotes localization and uptake by specific cell populations, such as tumor cells, and their conjugation to anti-cancer drugs has been explored for targeted therapy. Advancements in the development of polymeric nanoparticles allow anti-cancer drugs to be encapsulated in protective nonreactive shells for controlled drug delivery with reduced toxicity. The conjugation of aptamers to nanoparticle-based therapeutics may further enhance direct targeting and personalized medicine. Here we present how the combinatorial use of aptamer and nanoparticle technologies has the potential to develop “smart bombs” for targeted cancer treatment, highlighting recent pre-clinical studies demonstrating efficacy for the direct targeting to particular tumor cell populations. However, despite these pre-clinical promising results, there has been little progress in moving this technology to the bedside.
Targeted Oncology – Springer Journals
Published: May 21, 2015
Access the full text.
Sign up today, get DeepDyve free for 14 days.